Review Article
Iodine Status in the Colombian Population and the Impact of Universal Salt Iodization: A Double-Edged Sword?
Table 4
Studies evaluating IDDs in Colombia after its declaration as an IDD-free country.
| | Parameters evaluated | Year | | 1994–1998 | 1999 | 2001–2002 | 2006–2007 | 2010 | 2011 | 2013–2014 | 2015 |
| | Geographical area | U | U and R | U and R | U and R | U and R | U | U | Mainly U | | Population | School children () | School children () | School children () | School children () | School children () | Adults () | Pregnant women () | School children () | | Urinary iodine, mean in µg/L | ≥100 (in >90% of the population) | 380 (U: 705, R: 148) | 415 (U: 430, R: 380) | 272.4 (U: 285.5, R: 72.6) | 401.2 | 424.2 | 354 | 510.3 | | Goiter | 6.5% | NR | NR | NR | 88% | NR | 25.5% | 37.9% | | Anti-thyroid antibodies | NR | NR | NR | NR | Anti-TPO: 4% | Anti-TPO: 28.9% | Anti-TPO: 0.76% | Anti-TPO: 42.75%; anti-Tg: 2.87%; anti-TPO and anti-Tg: 3.62%; TRAb: 0% |
|
|
Anti-Tg: anti-thyroglobulin antibodies; anti-TPO: anti-thyroid peroxidase antibodies; IDD: iodine deficiency disorder; NR: not reported; R: rural; TRAb: TSH receptor antibodies; U: urban. Prevalence determined by palpation. Prevalence determined by immunoassay. |
